New antisense oligonucleotide therapies reach first base in ALS

被引：8
|
作者：
Lopez, Elia R. [1 ]
Borschel, William F. [1 ]
Traynor, Bryan J. [1 ,2 ]
机构：
[1] NIH, Therapeut Dev Branch, Natl Ctr Adv Translat Sci, Rockville, MD 20852 USA
[2] NIA, Lab Neurogenet, NIH, Bethesda, MD 20892 USA
来源：
NATURE MEDICINE | 2022年 / 28卷 / 01期
基金：
美国国家卫生研究院;
关键词：
HEXANUCLEOTIDE REPEAT; SHAM CONTROL; NUSINERSEN; C9ORF72;
D O I：
10.1038/s41591-021-01629-7
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Two studies highlight the evolution of antisense oligonucleotide therapy for amyotrophic lateral sclerosis, offering hope for an effective treatment.
引用
收藏
页码：25 / 27
页数：3
相关论文
共 50 条
  • [1] New antisense oligonucleotide therapies reach first base in ALS
    Elia R. Lopez
    William F. Borschel
    Bryan J. Traynor
    Nature Medicine, 2022, 28 : 25 - 27
  • [2] The sense of antisense therapies in ALS
    Van Daele, Sien H.
    Masrori, Pegah
    Van Damme, Philip
    Van Den Bosch, Ludo
    TRENDS IN MOLECULAR MEDICINE, 2024, 30 (03) : 252 - 262
  • [3] ANTISENSE OLIGONUCLEOTIDE THERAPIES - ARE THEY THE MAGIC BULLETS
    MA, DDF
    LEDOAN, T
    ANNALS OF INTERNAL MEDICINE, 1994, 120 (02) : 161 - 163
  • [4] Opportunities and challenges for antisense oligonucleotide therapies
    Kuijper, Elsa C.
    Bergsma, Atze J.
    Pijnappel, W. W. M. Pim
    Aartsma-Rus, Annemieke
    JOURNAL OF INHERITED METABOLIC DISEASE, 2021, 44 (01) : 72 - 87
  • [5] Antisense Oligonucleotide Therapies for Neurodegenerative Diseases
    Bennett, C. Frank
    Krainer, Adrian R.
    Cleveland, Don W.
    ANNUAL REVIEW OF NEUROSCIENCE, VOL 42, 2019, 42 : 385 - 406
  • [6] Ethical Issues in Individualized Antisense Oligonucleotide Therapies
    Kearns, Lisa
    MOLECULAR THERAPY, 2021, 29 (04) : 212 - 213
  • [7] A new antisense oligonucleotide therapy?
    Nicholas J. Bernard
    Nature Reviews Rheumatology, 2018, 14 : 685 - 685
  • [8] Antisense oligonucleotide treatment prolongs survival in an ALS rat model
    Miller, Timothy M.
    Smith, Richard
    McAlonis-Downes, Melissa
    Szwajkowski, Gabrielle
    Bennett, Frank
    Cleveland, Don
    NEUROLOGY, 2007, 68 (12) : A91 - A91
  • [9] Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS
    Miller, Timothy M.
    Cudkowicz, Merit E.
    Genge, Angela
    Shaw, Pamela J.
    Sobue, Gen
    Bucelli, Robert C.
    Chio, Adriano
    Van Damme, Philip
    Ludolph, Albert C.
    Glass, Jonathan D.
    Andrews, Jinsy A.
    Babu, Suma
    Benatar, Michael
    McDermott, Christopher J.
    Cochrane, Thos
    Chary, Sowmya
    Chew, Sheena
    Zhu, Han
    Wu, Fan
    Nestorov, Ivan
    Graham, Danielle
    Sun, Peng
    McNeill, Manjit
    Fanning, Laura
    Ferguson, Toby A.
    Fradette, Stephanie
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (12): : 1099 - 1110
  • [10] Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders
    Lauffer, Marlen C.
    van Roon-Mom, Willeke
    Aartsma-Rus, Annemieke
    COMMUNICATIONS MEDICINE, 2024, 4 (01):
12345